MedPath

Study on Gynecological Rare Cancers

Recruiting
Conditions
Gynecologic Cancer
Registration Number
NCT05733806
Lead Sponsor
National Cancer Institute, Naples
Brief Summary

This is a prospective, observational, multicenter study on gynecological rare tumors.

Detailed Description

This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
500
Inclusion Criteria
  • rare gynecological malignancies
  • written informed consent
  • patient fit for follow-up

Exclusion criteria

-written informed consent not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of gynecologic rare malignancies5 years

To describe the prevalence of gynecologic rare tumors

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele

🇮🇹

Milan, Italy

IRCCS Fondazione G Pascale

🇮🇹

Naples, Italy

Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele
🇮🇹Milan, Italy
Giorgia Mangili, MD
Contact
mangili.giorgia@hsr.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.